{"id":"W2318057464","doi":"10.1158/1535-7163.targ-09-b160","title":"Abstract B160: ANG1005: New EPiC compound for the treatment of recurrent malignant glioma","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Intrinsik (Canada); Angiochem (Canada)","funders":"","keywords":"Glioma; Medicine; Tolerability; Neutropenia; Adverse effect; Taxane; Internal medicine; Cancer; Oncology; Gastroenterology; Pharmacology; Cancer research; Breast cancer; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001309265,0.0002572249,0.0002376325,0.0003005654,0.00008703747,0.000208241,0.0002197295,0.0002477926,0.002483433],"category_scores_gemma":[0.00008239786,0.00008160317,0.000159004,0.0001606967,0.0001043554,0.0001472728,0.0001561644,0.0005831342,0.0007475573],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002382742,"about_ca_system_score_gemma":0.0002352071,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005517101,"about_ca_topic_score_gemma":0.001187318,"domain_scores_codex":[0.9999564,0.000007670042,0.000002688945,0.000007527904,0.00001493463,0.00001081668],"domain_scores_gemma":[0.9999683,0.000002500827,0.000007453919,0.000002864715,0.000003942151,0.0000148554],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005083571,0.002272883,0.002616822,0.0006496027,0.0001343878,0.000726397,0.00008741672,0.001213921,0.7070816,0.0008524042,0.006877098,0.2724039],"study_design_scores_gemma":[0.009789946,0.1090107,0.0689631,0.0002738358,0.0005182833,0.01065967,0.0001176835,0.008096583,0.6495789,0.0008104954,0.1420804,0.0001005073],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"other","genre_scores_codex":[0.9688996,0.01376274,0.002778703,0.0004503393,0.0001655928,0.0003268748,0.0008772117,0.0003599761,0.01237894],"genre_scores_gemma":[0.9805267,0.005764801,0.002661447,0.0004849921,0.00006273203,0.0001199067,0.001350084,0.00003088564,0.008998547],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.002483433,"threshold_uncertainty_score":0.008307874,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05376839915359866,"score_gpt":0.3395313373520377,"score_spread":0.2857629381984391,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}